Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 16Uterine Cervical Neoplasms 11Condylomata Acuminata 5Vulvar Neoplasms 3Anus Neoplasms 3Vaginal Neoplasms 2Whooping Cough 1Virus Diseases 1Uterine Cervical Dysplasia 1Tetanus 1Neoplasms, Glandular and Epithelial 1Meningitis 1Lung Neoplasms 1Diphtheria 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Vaccines 1Papillomavirus Vaccines 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Whooping Cough × Papillomavirus Vaccines × Clear all
NCT00325130 2015-03-12

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Merck Sharp & Dohme LLC

Phase 3 Completed
1,042 enrolled 26 charts

Diphtheria, Meningitis, Neoplasms, Glandular and Epithelial, Tetanus, Whooping Cough

Data powered by HemOnc (CC BY 4.0) Colophon âš¡